Cumberland Pharmaceuticals, based in Nashville, TN, is dedicated to improving patient care through the development and delivery of high-quality pharmaceutical products. Their portfolio includes FDA-approved treatments for serious bacterial infections, pain management, and prescription laxatives, with a focus on reducing the need for opioids.
With a commitment to corporate sustainability, Cumberland Pharmaceuticals engages in community involvement, ethical marketing practices, and drug safety policies. They are also actively expanding their pipeline to develop new medicines for the future, including a phase II candidate for patients with Duchenne muscular dystrophy.
Generated from the website